https://doi.org/10.1109/3dv.2017.00081
A
Anne Lynn S. Chang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
456
Papers
32.3K
Citations
70
h-index
184
i10-index
Anne Lynn S. Chang is an academic researcher from University of Waterloo. The author has contributed to research in topics: Nonmelanoma Skin Cancer Studies & Hedgehog Signaling Pathway Studies & Cancer and Skin Lesions. The author has an h-index of 70, co-authored 388 publications.
ORCID: 0000-0002-2869-2147Papers by this author
worksMatterport3D: Learning from RGB-D Data in Indoor Environments
2017 · 1,671 citations
Clonal replacement of tumor-specific T cells following PD-1 blockade
2019 · Nature Medicine · 1,488 citations
https://doi.org/10.1038/s41591-019-0522-3
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
2012 · New England Journal of Medicine · 1,419 citations
https://doi.org/10.1056/nejmoa1113713
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
2015 · The Lancet Oncology · 423 citations
https://doi.org/10.1016/s1470-2045(15)70100-2
Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
2015 · Cancer Cell · 415 citations
https://doi.org/10.1016/j.ccell.2015.02.002
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
2015 · Journal of the American Academy of Dermatology · 207 citations
https://doi.org/10.1016/j.jaad.2015.03.021
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat